We recently showed that overexpression of Dsg2 under the control of the involucrin promoter in the skin of transgenic mice (Inv-Dsg2) resulted in hyperplasia of the epidermis and enhanced sensitivity to tumor induction [5]. The gene discussed is IVL; the disease is neoplasm.